Azanta is a Danish specialty biopharmaceutical company developing treatments for orphan oncology and women’s health indications. We also have commercial sales activities primarily within oncology, women’s healthcare and addiction medicine.
Azanta’s mission is to make medicines available to patients and our customers because life matters. This mission is reflected in our focus areas where we aim to make medicines and health products available to prevent, treat or alleviate debilitating diseases and symptoms in order to improve people’s lives.
Azanta seeks to be an international market leader within certain niche specialty pharma product categories, employing innovative repositioning and drug formulation strategies, offering patients the best treatment alternatives.
We market our own and in-licensed products in the Nordics and other selected markets and work with license partners in the rest of the world. Our drug product development pipeline and in-licensing opportunities are selected with the view to supplement our existing portfolio of marketed products with the objective to offer medical solutions and patient care where there are unmet medical needs.
Our organization is structured with a lean and flexible in-house strategic high calibre team supplemented with in-sourced expert capabilities.
We value the individuality of our customers and seek to service our customers and collaborators in the best possible manner. Every day, we are committed and work enthusiastically to meet the demands of our business and customers.